NCT06342362View on ClinicalTrials.gov

"Magnesium Sulfate in Neonatal HIE"

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

April 2, 2024

Primary Completion Date

October 2, 2024

Study Completion Date

December 2, 2024

Conditions

Neonates With HIE

Interventions

DRUG

Magnesium sulfate

Participants would be randomly assigned to either the treatment group (receiving magnesium sulfate) or the control group (receiving a placebo or standard treatment).

OTHER

placebo or standard treatment)

Trial Locations (1)

74201

SICHN, Karachi

All Listed Sponsors

lead

Sindh Institute of Child Health and Neonatology

OTHER

NCT06342362 - "Magnesium Sulfate in Neonatal HIE" | Biotech Hunter | Biotech Hunter